Translating novel carbon coating towards integrated sub-second neurotransmitter sensors in humans

Active Grant Awarded

Award ID
R18NS145979
Recipient
Awarding agency
Obligated
$1,010,880

Award facts

Completion date 18% complete
Place of performance
Hanover, NH 03755, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded Trustees of Dartmouth College $1.01088 million on May 4, 2026, under Assistance Listing 93.372, 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies. The award funds translation of a novel carbon coating for sub-second neurotransmitter sensing in humans. Dartmouth's team validated a prototype integrated probe that combines parallel spike and local-field-potential recording with fast-scan cyclic voltammetry, tested in vivo in rodents. Three parallel aims will develop designs to translate this technology to NeuroOne's SEEG electrode, with the goal of first-in-human studies. The work involves Dartmouth, the VA Medical Center, Beth Israel Deaconess Medical Center, and NeuroOne. Performance runs through April 30, 2029, at Hanover, New Hampshire 03755.

Three federal grant sub-awards pass funding through to collaborators. Beth Israel Deaconess Medical Center, Inc. received a sub-award dated September 3, 2026, under the award's project title. NeuroOne Medical Technologies Corporation received a sub-award dated September 10, 2026, under the title "BRAIN Initiative Industry Partnership Program to Facilitate Early Access to Neuromodulation and Recording Devices for Human Clinical Studies." Veterans Education and Research Association of Northern New England, Inc. received a sub-award dated September 15, 2026, under the award's project title.

Description

Abstract
Neurotransmitter sensing is important for both the fundamental understanding and clinical treatment of many diseases and conditions. However, currently, there are no FDA-cleared or -approved medical devices that can sense neurotransmitters within the living human brain. This application aims to fill this important GAP by translating recent neurochemical sensor innovation through collaboration among academia (dartmouth and VA medical center), neurosurgery (beth israel deaconess medical center), and industry (NEUROONE). Recently, we discovered that mild annealing dramatically improved the electrochemical stability of electroplated carbon coating and transformed conventional microelectrodes into sensors similar to carbon fiber electrodes with excellent neuromodulator-sensing performance based on fast-scan cyclic voltammetry (FSCV). Based on this discovery, we created a prototype integrated probe that combines both electrical recording and FSCV capabilities and validated IT in vivo in rodents, demonstrating parallel spike/local-field-potential -recording and sub-second dopamine sensing with synergistic multimodal results. In three parallel aims, we will develop designs to translate this novel technology to NEUROONE's seeg electrode, which is the first and only thin-film neural electrode FDA-cleared in clinics, with the goal of achieving the most efficient and effective translation towards first-in-human studies. Our long-term goal is to shift the current neurophysiological monitoring and recording paradigm from electrophysiology only to electrophysiology combined with chemical sensing by integrating interoperable neurotransmitter sensors. While we only focus on seeg electrodes here for the sensor integration, we envision that the translational optimization of FSCV-stable carbon coating, the clinical- facing potentiostat and software design, and the regulator pathway developed are generalizable to standalone neurochemical sensors in humans or similar integrations on many emerging device platforms, such as thin-film DBS electrodes and intracortical arrays.

Subawards

Subrecipient Amount Awarded
Veterans Education And Research Association Of Northern New England, Inc. Translating Novel Carbon Coating Towards Integrated Sub-second Neurotransmitter Sensors in Humans $126,213
Neuroone Medical Technologies Corporation BRAIN Initiative Industry Partnership Program to Facilitate Early Access to Neuromodulation and Recording Devices for Human Clinical Studies $199,626
Beth Israel Deaconess Medical Center, Inc. Translating Novel Carbon Coating Towards Integrated Sub-second Neurotransmitter Sensors in Humans $67,168

Quick answers

Who received award R18NS145979?

R18NS145979 was awarded to Trustees Of Dartmouth College by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on May 4, 2026.

How much is award R18NS145979 worth?

$1,010,880 has been obligated on R18NS145979.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award